Barack Obama’s science advisor, John Holdren, declared, “The Administration believes that altering the human germline for clinical purposes is a line that should not be crossed at this time,” and the director of the National Institutes of Health, Francis Collins, announced, “The NIH will not fund any use of gene-editing technologies in human embryos.”
